Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	185.68	145.49	128.85	181.47	34.6	-36.94
Depreciation & Amortization	23.87	24.11	24.36	23.39	18.84	10.24
Other Amortization	0.66	0.7	2.27	1.66	2.24	2.41
Asset Writedown & Restructuring Costs	31	43.6	2.26	-	-	2
Loss (Gain) From Sale of Investments	-1.73	-2.26	-2.72	-0.43	-	-
Stock-Based Compensation	45	42.6	31.71	26.17	15.66	4.69
Other Operating Activities	-20.46	-27.1	-2.38	-83.69	26.59	26.25
Change in Accounts Receivable	-19.15	-8.89	-19.4	-19.9	-12.67	-17.92
Change in Inventory	0.03	-1.84	-1.07	0.14	-0.61	-2.74
Change in Accounts Payable	15.81	-5.38	8.95	2.79	-1.56	-3.8
Change in Other Net Operating Assets	36.9	8.79	46.55	12.87	15.46	12.83
Operating Cash Flow	297.61	219.82	219.39	144.47	98.56	-2.99
Operating Cash Flow Growth	34.71%	0.20%	51.86%	46.58%	-	-
Capital Expenditures	-0.72	-1.15	-0.31	-0.17	-0.3	-0
Cash Acquisitions	-	-33.07	-36.97	-	-	-
Sale (Purchase) of Intangibles	-16	-26.5	-	-40	-100	-2
Investment in Securities	-12.49	-6.76	-9.16	-101.66	-	-
Investing Cash Flow	-29.2	-67.48	-46.44	-141.83	-100.3	-2
Long-Term Debt Issued	-	-	200	-	200	200
Long-Term Debt Repaid	-	-15	-201.25	-2	-200.5	-102.54
Net Debt Issued (Repaid)	-15	-15	-1.25	-2	-0.5	97.46
Issuance of Common Stock	10.79	6.5	5.06	8.84	39.37	147.93
Repurchase of Common Stock	-4.57	-2.5	-100.51	-	-	-0.18
Other Financing Activities	-	-	-8.84	-	-31.45	-36.04
Financing Cash Flow	-8.78	-11	-105.55	6.84	7.42	209.16
Net Cash Flow	259.63	141.34	67.4	9.48	5.68	204.17
Free Cash Flow	296.89	218.67	219.08	144.29	98.26	-2.99
Free Cash Flow Growth	34.84%	-0.19%	51.82%	46.85%	-	-
Free Cash Flow Margin	35.95%	30.59%	37.64%	32.95%	32.17%	-1.87%
Free Cash Flow Per Share	5.07	3.78	3.63	2.36	1.66	-0.12
Cash Interest Paid	15.32	17.32	20.05	16.36	19.83	26.2
Cash Income Tax Paid	56.52	79.64	48.23	12.65	2.88	-
Levered Free Cash Flow	187.59	143.91	214.33	72.97	-123.53	96
Unlevered Free Cash Flow	196.5	154.14	226.91	83.05	-110.64	111.47
Change in Working Capital	33.6	-7.32	35.04	-4.11	0.63	-11.63

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q